Recital 8, Regulation (EU) 2024/20

In forcesince 12 Dec 2023

On 29 September 2022, given that all areas of the assessment, except for endocrine disrupting properties, had been completed and that several critical areas of concern had been identified, the Commission invited the Authority to provide the results of the risk assessment of the active substance S-metolachor, including its conclusion as to whether S-metolachlor can be expected to meet the approval criteria set out in Article 4 of Regulation (EC) No 1107/2009 excluding the full assessment of endocrine disrupting properties.